Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System
Background: Immune checkpoint inhibitors (ICIs) improve cancer survival but can provoke new or worsening autoimmune disease. Objectives: To explore the association of ICIs with multiple sclerosis (MS) using the U.S. Food and Drug Administration’s Adverse Event Reporting System (FAERS) database, and...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
SAGE Publishing
2025-11-01
|
| Rangatū: | Therapeutic Advances in Neurological Disorders |
| Urunga tuihono: | https://doi.org/10.1177/17562864251392211 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|